R-Evolution Worldwide is glad to announce the launch of a collaboration with the University of Salento, (the local University, in southern Italy) and with the University of Sciences, Techniques and Technologies of Bamako, in Mali, in the context of an innovative PhD on the topic of “Malaria and drug resistance: development of new therapeutic strategies”.
This PhD involves one of the scientific project coordinators of the company, Dr. Sara Greco, starting from 9th December 2024.
The NeuroSolve consortium held its Project Kick-off Meeting on the 4th December 2023 in Lusaka (Zambia). NeuroSolve is a four-year project funded by EDCTP3, lead by an African-European research consortium
PRECISION-asympTB was submitted under the EDCTP3 2026 Call on Tuberculosis. Despite decades of global efforts, TB remains one of the leading infectious causes of death worldwide. One of the greatest challenges today
Tuberculosis (TB) remains one of the leading infectious diseases worldwide. According to the WHO Global Tuberculosis Report, in 2023 an estimated 10.8 million people developed TB globally, and about 1.25